Choosing between a SPAC and an IPO is about cost of capital, certainty of outcome, timing and the investor base you want to ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...

LB Pharma needed $350 million to advance a promising schizophrenia candidate at a time when the biotech markets were locked up tight. Fortunately, it wasn’t CEO Heather Turner’s first rodeo.

Prediction markets like Kalshi have attracted significant interest, especially in recent years.

Though sparse by New York standards, the prospective offerings are a sharp pickup for an IPO market that’s been mired in a ...

Reddit will allow its most active users to buy shares in its IPO. But many of those users are skeptical it will succeed.

Why the IPO market took off in 2025. In this podcast, Motley Fool analysts Emily Flippen and Sanmeet Deo and contirubtor Jason Hall break down why the IPO market took off in 2025, which new listings ...

Discover how laddering strategies help investors manage risks in bonds and fixed-income products, and learn about its controversial role in IPOs for boosting stock prices.

Last year saw a phenomenal rise in the number of public listings, mergers and acquisitions in the world of crypto. As for 2026, the party is just getting started. This week, crypto custodian BitGo is ...

In this podcast, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discuss: Rocket Lab's test failure. SpaceX's IPO rumors and who could quickly follow. Investing advice when analyzing ...

Explore the top crypto presale for 2026? IPO Genie combines AI deal screening, a $1M raise, Redwood AI proof, plus 35% bonus ...